Cefixime Dosage for Typhoid Fever in Children
For children with typhoid fever, administer cefixime at 8 mg/kg/day orally, divided into two doses (4 mg/kg every 12 hours) for 7-14 days, with a maximum daily dose of 400 mg. 1
Standard Dosing Protocol
The FDA-approved dosing for cefixime oral suspension in pediatric patients (≥6 months) is:
- 8 mg/kg/day administered as:
- Single daily dose, OR
- Divided into two doses of 4 mg/kg every 12 hours
- Maximum dose: 400 mg/day
- Duration: 7-14 days (typically 7-10 days for typhoid)
Weight-Based Dosing Table 1
For practical administration:
- 5-7.5 kg: 50 mg/day (2.5 mL of 100 mg/5 mL suspension)
- 7.6-10 kg: 80 mg/day (4 mL of 100 mg/5 mL or 2 mL of 200 mg/5 mL)
- 10.1-12.5 kg: 100 mg/day (5 mL of 100 mg/5 mL or 2.5 mL of 200 mg/5 mL)
- 12.6-20.5 kg: 150 mg/day (7.5 mL of 100 mg/5 mL or 4 mL of 200 mg/5 mL)
- 20.6-28 kg: 200 mg/day (10 mL of 100 mg/5 mL or 5 mL of 200 mg/5 mL)
- Children >45 kg or >12 years: 400 mg/day (adult dose)
Critical Clinical Context
Important Limitations
Cefixime is NOT the first-line treatment for typhoid fever. Current WHO guidelines recommend fluoroquinolones (where sensitive), azithromycin, or ceftriaxone as preferred agents 2. Cefixime is listed as an alternative option, particularly for multidrug-resistant strains where fluoroquinolones remain sensitive 2.
Evidence of Reduced Efficacy
Recent research demonstrates significant concerns with cefixime:
- Clinical failure rates of 27% compared to 1% with gatifloxacin 3
- Longer fever clearance time: 8.5 days with cefixime vs 4.4 days with ofloxacin 4
- Higher treatment failure: 69.4% resistance reported in recent surveillance 5
- One study showed cefixime had 37.6% overall treatment failure vs 3.5% with gatifloxacin 3
When Cefixime May Be Appropriate
Consider cefixime only when:
- Multidrug-resistant strains are present AND organism remains cefixime-sensitive
- Fluoroquinolones are contraindicated or resistance documented
- Oral route is essential and ceftriaxone (IV/IM) cannot be used
- Azithromycin is unavailable or contraindicated
Preferred Alternatives
Based on current guidelines and evidence 2:
- First-line: Azithromycin (20 mg/kg/day for 7 days, max 1 g/day) - 96.7% sensitivity 5
- Second-line: Ceftriaxone (50-75 mg/kg/day IV, max 2-4 g/day) - 38.7% sensitivity but better for severe cases 5
- Third-line: Fluoroquinolones (if locally sensitive)
- Alternative: Cefixime (only if above unavailable and organism sensitive)
Critical Pitfalls to Avoid
- Do NOT use cefixime empirically without considering local resistance patterns - resistance rates exceed 69% in some regions 5
- Do NOT continue cefixime if fever persists beyond 5-7 days - switch to ceftriaxone or azithromycin 3, 4
- Do NOT assume all cephalosporins are equivalent - ceftriaxone performs significantly better than cefixime 6
- Monitor for treatment failure - expect defervescence by day 4-5; if not, consider resistance and change therapy 7, 3
Duration Considerations
- Minimum: 7 days for uncomplicated cases
- Standard: 10 days (most common in studies) 8
- Extended: Up to 14 days if slow clinical response 7
The emergence of extensively drug-resistant (XDR) typhoid strains means cefixime should be reserved as a last-resort oral option only when better alternatives are unavailable or contraindicated. 9, 5